Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
DOMAIN PARTERS VII L P
- As of  04/27/24, 01:45:59 PM:   26 Insider Transactions.

Email this page to a friend.

Buy/Sell* 1 Yr Return** Filed Date Subject Symbol Pct Owned Details
B 2020-10-23 16:30:02.0 OBALON THERAPEUTICS INC OBLN 28.7% view
B 2019-08-08 16:16:03.0 OBALON THERAPEUTICS INC OBLN 28.7% view
S 2019-01-11 10:56:46.0 Evofem Biosciences EVFM 2.0% view
S 2018-08-31 12:50:33.0 OBALON THERAPEUTICS INC OBLN 28.7% view
B 2018-01-29 13:25:01.0 Esperion Therapeutics ESPR 25.93% view
B 2017-12-08 16:26:11.0 Esperion Therapeutics ESPR 25.93% view
B 2017-01-09 13:02:09.0 Evoke Pharma Inc EVOK 48.34% view
B 2017-01-09 12:59:36.0 OBALON THERAPEUTICS INC OBLN 52.92% view
S 2016-01-19 15:49:50.0 Evoke Pharma Inc EVOK 14.6% view
S 2015-09-25 16:35:41.0 Clovis Oncology CLVS 3.4% view
S 2015-03-25 16:45:50.0 Esperion Therapeutics ESPR 11.2% view
S 2015-03-10 13:47:38.0 Clovis Oncology CLVS 6.1% view
B 2015-02-05 14:46:20.0 Neothetics NEOT 22.3% view
B 2015-02-05 08:46:05.0 Achaogen Inc n/a 11.1% view
S 2014-10-30 16:56:08.0 Esperion Therapeutics ESPR 13.3% view
B 331.96% 2014-02-06 15:04:21.0 Esperion Therapeutics ESPR 13.9% view
B 2014-02-06 14:59:31.0 Evoke Pharma Inc n/a 18.3% view
B -44.16% 2014-02-06 14:52:01.0 TANDEM DIABETES CARE INC TNDM 15.2% view
S 2013-06-05 17:33:03.0 Clovis Oncology CLVS 9.8% view
B 194.15% 2012-01-13 17:30:16.0 Orexigen Therapeutics OREX 14.4% view
B -5.26% 2011-11-21 17:16:22.0 Clovis Oncology CLVS 13.8% view
S 2011-10-03 14:32:51.0 ZOGENIX ZGNX 15.4% view
B -72.07% 2010-12-09 16:48:21.0 ZOGENIX ZGNX 19.3% view
S 2009-12-03 13:00:57.0 Orexigen Therapeutics OREX 7.5% view
S 2009-08-20 16:52:28.0 Orexigen Therapeutics OREX 7.6% view
B -42.35% 2009-07-30 16:54:25.0 Orexigen Therapeutics OREX 7.7% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.
** Since most institutions are long investors, only returns for long transactions are shown here.